TECX20260417C25
TECX Apr 17 2026 25.00 Call (TECX260417C00025000)
option OPRA

EOD

Mar 26, 2026

7.21+47.143%(+2.31)1

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

Sector

Professional, Scientific, and Technical Services

Profile

clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.

Share

Connect with us

.dark-mode .SktxFS{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .SktxFS{ color: #333333; background-color: white; border: 2px solid #333333; }TECX20260417C25TECX Apr 17 2026 25.00 Call (TECX260417C00025000)option OPRA